Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
| Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms |
| Autore | Segelov Eva |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (144 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
small bowel neuroendocrine tumours
pancreatic neuroendocrine tumours liver metastases midgut meta-analysis neuroendocrine tumors carcinoid heart disease carcinoid syndrome somatostatin analogues metastases multidisciplinary management outcome grading staging neuroendocrine neoplasms chemotherapy temozolomide metronomic treatment second-line NOTCH cancer-driven genes mutational mechanism germline mutations small cell lung carcinoma pancreatic NET small bowel NET medullary thyroid carcinoma malignant castration-resistant prostatic cells quality performance indicators QPIs cancer care neuroendocrine tumour NETs modified Delphi CommNETs pancreatic neuroendocrine neoplasms neuroendocrine tumor long-term functional outcomes pancreatectomy diabetes mellitus pancreatic exocrine insufficiency body mass index parenchyma-sparing surgery neuroendocrine tumours curative surgery resection follow-up guidelines relapse recurrence risk factor mixed non-neuroendocrine neuroendocrine neoplasms MiNENs mixed adeno-neuroendocrine carcinoma MANEC 2017 WHO classification 2019 WHO classification |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557692903321 |
Segelov Eva
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Present and Future of Personalised Medicine for Endocrine Cancers
| Present and Future of Personalised Medicine for Endocrine Cancers |
| Autore | Ronchi Cristina L |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (140 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
papillary thyroid cancer
SUV PET/CT BRAF V600E immune checkpoint inhibitors (ICIs) ipilimumab nivolumab prolactinoma Cushing's disease aggressive pituitary tumor aggressive PitNET aggressive pituitary adenoma pituitary carcinoma adrenocortical cancer adrenal adenomas adrenal tumors p53 p27 ki-67 reticulin mitotane adjuvant treatment recurrence recurrence free survival timing intratumoral heterogeneity thyroid tumor BRAF RET/PTC rearrangements RAS mutation adrenal cortex carcinoma angiogenesis gene expression osteopontin hyaluronan synthase 1 multikinase inhibitors sorafenib lenvatinib differentiated thyroid cancer radioiodine resistance predictive marker predictors response to treatment survival information needs and preferences focus group interview personalized medicine neuroendocrine tumours phaeochromocytoma paraganglioma molecular clusters |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576879703321 |
|
Ronchi Cristina L
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||